Date Title Description PDF
02 Mar 2021 On business and financial situation The Company releases a presentation related to an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States  Download
24 Feb 2021 About corporate governance The Company informs about the agreements adopted by the Board of Directors  Download
27 Nov 2020 On business and financial situation The Company publishes the results of the PRISMA-3 study of the efficacy and safety of Doria® in schizophrenic patients in the journal npj Schizophrenia Download
09 Jul 2020 On business and financial situation ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Download

Pages

Date Title Description PDF
20 Oct 2020 Announcement of general shareholders’ meeting ROVI releases the information related to its General Shareholders Meeting Download
15 Oct 2020 Announcement of general shareholders’ meeting   In view of the exceptional circumstances derived from the spread of Covid-19, the Company has agreed that the Ordinary General Meeting be held by exclusively telematic means.   Download
01 Oct 2020 Liquidity contracts and specialists Liquidity contract: transactions conducted in the third quarter of 2020 Download
11 Sep 2020 Announcement of general shareholders’ meeting Rovi releases the information related to its 2020 General Shareholders Meeting. Download
27 Jul 2020 On business and financial situation The company releases the press release related to the 2020 first half financial results Download

Pages

Date Title Description PDF
21 Dec 2011 Acuerdos estratégicos con terceros (2) Download
21 Dec 2011 Acuerdos estratégicos con terceros Download
08 Nov 2011 Información sobre resultados (2) Download
08 Nov 2011 Información sobre resultados Download
08 Nov 2011 Composición de otros órganos de gestión y control Download

Pages